These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 36157551

  • 1. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J, Klammer M, Rolny V, Chan HL, Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, Swiatek-de Lange M.
    World J Gastroenterol; 2022 Aug 07; 28(29):3917-3933. PubMed ID: 36157551
    [Abstract] [Full Text] [Related]

  • 2. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
    Xu F, Zhang L, He W, Song D, Ji X, Shao J.
    Dis Markers; 2021 Aug 07; 2021():8868370. PubMed ID: 33628341
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.
    Guan MC, Ouyang W, Liu SY, Sun LY, Chen WY, Tong XM, Zhu H, Yang T.
    Hepatobiliary Pancreat Dis Int; 2022 Dec 07; 21(6):559-568. PubMed ID: 35643910
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
    Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM.
    World J Gastroenterol; 2019 Sep 28; 25(36):5515-5529. PubMed ID: 31576097
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
    Tian Z, Yu T, Wei H, Ning N.
    J Clin Lab Anal; 2020 Feb 28; 34(2):e23071. PubMed ID: 31693242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM, Morsi HK, Abdulateef NA, Noaman MK, Abou El-Ella GA.
    Scand J Clin Lab Invest; 2017 May 28; 77(3):175-183. PubMed ID: 28276727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H, Li B, Li Z, Wei Q, Ren L.
    BMC Cancer; 2021 Apr 13; 21(1):401. PubMed ID: 33849479
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z.
    Int J Cancer; 2015 Oct 01; 137(7):1679-90. PubMed ID: 25845839
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.
    Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, He Y, Swiatek-de Lange M, Morgenstern D, Chan HL.
    Hepatol Commun; 2022 Apr 01; 6(4):679-691. PubMed ID: 34796691
    [Abstract] [Full Text] [Related]

  • 19. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH.
    Scand J Gastroenterol; 2016 Mar 01; 51(3):344-53. PubMed ID: 26340708
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels.
    Syriha A, Pantzios S, Mandilara D, Galanis P, Stathopoulou I, Barla G, Elefsiniotis I.
    Cancer Med; 2024 Feb 01; 13(3):e6825. PubMed ID: 38361401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.